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Abstract 
Upper extremity (UE) hemiparesis persists after stroke, limiting hand 
function. Neuromuscular electrical stimulation (NMES) is an effective 
intervention to improve UE recovery, although the underlying mechanisms are 
not fully understood. Our objective was to establish a reliable protocol to 
measure UE agonist–antagonist forearm monosynaptic reflexes in a pilot 
study to determine if NMES improves wrist function after stroke. We 
established the between-day reliability of the H-reflex in the extensor carpi 
radialis longus (ECRL) and flexor carpi radialis (FCR) musculature for 
individuals with prior stroke (n = 18). The same-day generation of ECRL/FCR 
H-reflex recruitment curves was well tolerated, regardless of age or UE 
spasticity. The between-day reliability of the ECRL H-reflex was enhanced 
above FCR, similar to healthy subjects [20], with the Hmax the most reliable 
parameter quantified in both muscles. H-reflex and functional measures 
following NMES show the potential for NMES-induced increases in ECRL Hmax, 
but confirmation requires a larger clinical study. Our initial results support the 
safe, easy, and efficacious use of in-home NMES, and establish a potential 
method to measure UE monosynaptic reflexes after stroke. 
Keywords: Stroke, H-reflex, FCR, ECRL, Upper extremity spasticity, 
Neuromuscular electrical stimulation 
1. Introduction 
According to the American Heart Association, stroke is the 
leading cause of long-term adult disability, with annual healthcare 
costs exceeding $73 billion. Stroke-related upper extremity (UE) 
hemiparesis limits voluntary finger and wrist extension, and decreases 
hand function. Recovery from UE hemiparesis continues for months 
and is a self-reported major obstacle to quality of life [1], reducing the 
potential for the stroke survivor to live independently at home [4]. 
Physical therapy may improve UE hemiparesis, although the ‘best 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience Letters, Vol 535, (February 22, 2013): pg. 1-6. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
3 
 
practices’ regarding the specific modality, frequency or duration of 
therapy to reduce stroke-related disability require further 
investigation. 
Neuromuscular electrical stimulation (NMES) is a therapeutic 
intervention that delivers electrical impulses through the skin to 
repeatedly activate muscles [2]. NMES facilitates UE motor recovery in 
paretic limbs during acute [8] and chronic [19,17] stroke. Our data 
showed that wrist and hand impairment was significantly improved in 
a small sample of individuals with chronic stroke after only two weeks 
of NMES therapy [17]. The mechanisms underlying NMES-driven 
changes in motor function remain unclear, but may include enhanced 
cortical plasticity [19,10] and motor unit-derived CNS plasticity [15]. 
We hypothesized that NMES delivery to the UE of chronic stroke 
survivors would also modulate the excitability of the spinal reflexes, 
thus reducing spasticity and improving motor function. 
Determining monosynaptic reflex changes requires a reliable 
measure with low variability. We developed a protocol to measure the 
Hoffman (H)-reflex in both the extensor carpi radialis longus (ECRL) 
and the flexor carpi radialis (FCR) across days in healthy adults [20]. 
The assessment of agonist–antagonist muscles is key, as stroke 
suppresses the ECRL H-reflex and consequent EMG activity [12], which 
exacerbates FCR spasticity [16]. The first purpose of the pilot study 
was to determine if ECRL/FCR H-reflexes could be reliably measured 
between days in the affected extremity of participants with chronic 
stroke. Our second purpose was to quantify H-reflex plasticity 
following NMES intervention in the affected UE to determine if H-reflex 
modulations contribute to the beneficial effects of NMES therapy. Our 
preliminary data suggest that measuring ECRL/FCR H-reflexes is safe 
and well tolerated, and UE spasticity does not affect between-day H-
reflex measurement. In a small cohort of subjects, NMES increases 
ECRL activity, although we lack adequate power to conclude a relation 
to improved motor function. Our results establish a protocol to 
measure UE H-reflexes in a larger clinical trial to advance our 
understanding of the mechanisms by which NMES improves functional 
recovery after stroke-related UE hemiparesis. 
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2. Methods 
Eighteen participants with a confirmed diagnosis of chronic 
ischemic stroke (25–82 years of age; 10 M; 8 Fe; 62 ± 15 years) 
participated in this study (Table 1). All participants but one lived at 
home, and all gave written informed consent. We enrolled stroke 
survivors 1–10 years post-stroke. Participants were not excluded 
based on passive or active range of motion of the affected UE, but 
exclusion criteria included: (1) pregnancy; (2) cardiac pacemaker; (3) 
neurodegenerative disease; (4) tennis elbow/carpal tunnel syndrome; 
(5) UE pain. All participants had a Mini-Mental Status Exam ≥ 24, 
written physician approval for participation, and no concurrent 
rehabilitative therapies. The Human Subjects Institutional Review 
Board for the Kansas University Medical Center approved the 
experimental design. 
Table 1. CVA Participants. 
 
Subjects Gender Age, y Stroke, y 
Treatment 
group 
Affected 
hemisphere 
Orpington (0–5.2 
points) 
1 M 75 7 I/C Right 2 
2 M 75 5 C/I Right 2.4 
3 Fe 58 1 I Brain stem 2.8 
4 M 60 5 C Right 2.4 
5 Fe 46 4 C Right 2 
6 M 63 8 I/C Bilateral 4 
7 M 67 5 C/I Left 2 
8 Fe 43 3 I Left 2.4 
9 Fe 76 10 I Right 4 
10 Fe 25 3 C/I Right 1.6 
11 Fe 77 2 I Right 3.2 
12 M 77 5 I Right 2 
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Subjects Gender Age, y Stroke, y 
Treatment 
group 
Affected 
hemisphere 
Orpington (0–5.2 
points) 
13 M 63 6 I Right 3.2 
14 M 57 3 I Right 3.6 
15 Fe 53 3 C/I Left 3.6 
16 Fe 82 6 C/I Left 3.6 
17 M 71 4 C Left N/A 
18 M 59 3 I Right 3.2 
y, year; M, male; F, female; I, intervention; C, control. 
3. Experimental design 
On the first day, baseline stroke-related UE dysfunction was 
established (Table 1). The affected UE ECRL and FCR H-reflexes were 
measured over two consecutive days (‘Baseline’) before being 
randomized by coin toss into Control or Intervention. Intervention 
underwent NMES 30 min/day/10d, while Control continuously 
ambulated at a self-selected velocity for 30 min/day/10d. H-reflex and 
UE evaluation occurred immediately following NMES (Post) and 2 
weeks later (Retention). Testing order was counterbalanced between 
days, and sessions were scheduled at the same time each day. After 
Retention, Control participants that chose to enter the Intervention 
group began NMES. Two Intervention participants returned at 3 month 
and 6 month following testing to participate in Control, at times when 
we assume there was no effect of NMES on UE motor performance. 
At baseline, Orpington Prognostic Test established stroke 
severity [22]. Additional clinical tests of UE motor performance, speed, 
and function performed at every timepoint included: (1) Stroke impact 
scale (SIS), including the physical domain to assess UE function [5]; 
(2) modified Ashworth spasticity scale (MASS)(6); (3) Box and Block 
(BB) test to measure manual dexterity (6); (4) Fugl–Meyer (FM) test 
of sensorimotor impairment (6). Two participants were unable to 
complete BB due to severely impaired UE range of motion. 
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4. H-reflex measurement 
We previously established methods for measuring ECRL and FCR 
H-reflexes [20]. For this study, we measured the H-reflex in the 
affected UE contralateral to the lesioned hemisphere. Briefly, a 
constant current stimulator and isolation unit was used (Digitimer 
DS7A, Hertfordshire, England; 50 μA–200 mA; total output capability – 
400 V) with bipolar surface electrodes (Ambu; Ballerup, Denmark) 
placed over the radial [14] or median [9] nerve to elicit ECRL and FCR 
H-reflexes, respectively (Fig. 1). EMG signals were recorded (DelSys 
Inc. Boston, MA) and pre amplified before remote differential 
amplification. Data were sampled online (10,000 Hz) using a 16-bit 
analog to digital converter (National Instruments; Austin, TX) with a 
custom-designed data acquisition program (Labview, National 
Instruments). In order to optimize H-reflex signals and minimize 
fatigue, yet maintain the UE postures between test sessions, we chose 
a relaxed ECRL limb position of pronation/wrist extension, and 
supination/wrist flexion for FCR recordings [20]. A 227 g weight was 
held and tolerated by all participants except three (subjects 6, 11, 16), 
who lacked UE strength to hold the weight during testing. No H-reflex 
was recorded in FCR (subjects 15, 16) or ECRL (subjects 4, 9), but 
was found in the antagonist muscle; so data from these participants 
were not excluded. During testing, stimulation intensity was increased 
in 0.2–0.3 mA increments from below H-reflex threshold to the point 
on the recruitment curve where H-reflex amplitude declined; then 
stimulation intensity was increased in larger increments (~5 mA) until 
maximum M-wave amplitude. Three pulses (1 ms/0.2 Hz) were 
delivered at each intensity level with a 5 ms inter-pulse interval to 
minimize muscle fatigue. 
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Fig. 1. Stimulation parameters in the affected UE. The stimulating and recording 
electrode placement are shown in the left panels, and the corresponding H-reflex 
(black diamonds) and the M wave (grey squares) recruitment curves in the right 
panels for ECRL and FCR of subjects (A) 13 and (B) 10.  
5. NMES protocol 
NMES protocol has been previously reported from our laboratory 
[17]. On Day 2, Intervention participants received the first NMES 
intervention using a portable electrical stimulator (Rehabilicare; 
Windham, NH), with electrode placement determined by a physical 
therapist. A symmetrical, biphasic waveform (300 μs pulse width; 40 
Hz; 2 s on/off ramp; 6 s hold; 20 s rest) was applied to the affected 
UE in alternating extensor/flexor muscle contraction (30 min), 
approximately 60 muscle contractions/session [15]. After sufficient 
training, participants self-administered NMES at home, for 9 days/30 
min/sessions, with additional training for the spouse/caregiver when 
requested. Stimulus intensity was adjusted for individual subject 
tolerance at a level which produced a visible muscle contraction 
without discomfort. 
6. Data processing and analysis 
Peak-to-peak amplitudes for between-day reliability were 
calculated (Matlab; MathWorks-Natick, MA) [20]. Mean EMG amplitude 
for the H-reflex and M-wave were computed at each intensity and 
expressed as a proportion of the maximum M-wave to calculate the H-
reflex peak amplitude (Hmax), gain (HGN, bestfit slope of the rise to 
Hmax), and threshold (HTH, x-intercept of the HGN), each a descriptor 
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of the monosynaptic reflex excitability [20]. We also used an 
alternative visual (visHTH) method to determine the threshold based 
on the first visual sighting of the H-reflex during EMG data collection 
[20]. Recruitment curves were analyzed by an unbiased observer who 
determined atypical recruitment curves due to intermittent EMG signal, 
high signal:noise ratio, lack of a confirmed EMG plateau for Mmax, or 
cross-talk EMG signals from other activated muscles. Of the 93 
recruitment curves recorded in participants, 71 were established as 
physiologically representative, a similar percentage to prior results 
[20]. 
7. Statistical analysis 
Mean values ± standard deviations (SD) were calculated on 
each day for the FCR and ECRL muscles. Between days 1 and 2, paired 
t-tests were performed (muscle× Day) to assess significant changes 
for each variable (p < 0.05), and repeated measures ANOVA between 
day 2 (pre), post, and retention time points. Interclass correlation 
coefficients (ICCs) were calculated between days 1 and 2, as were 
typical error and typical percent error. The latter computations 
represented within-subject standard deviation and provided an 
indication of required treatment effect to be clinically meaningful [7]. 
8. Results 
8.1. Establishing a reliable UE H-reflex measure after 
stroke 
Throughout testing, the EMG signal for the H-reflex and M wave 
(e.g. latency of signal onset, waveform), and generation of 
recruitment curves (Fig. 1) in the affected UE did not differ from 
healthy subjects [20]. Table 2 and Fig. 2 depict between-day group 
means and individual subject variation for Hmax, HGN, HTH, and 
visHTH. Typical error and typical percent error are also presented for 
each H-reflex measure. Overall, the ECRL H-reflex yielded higher ICCs, 
and thus more reliable measures, than the FCR. For the ECRL muscle, 
between-day analysis for Hmax was dependable (ICC = 0.71), 
although the Hmax decreased amplitude on the second day (day 1, 
48% Mmax vs. day 2, 38% Mmax; p < 0.05). The ECRL HGN also 
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exhibited fair reliability (ICC = 0.74) despite large individual between-
day changes in amplitude. Neither HTH nor visHTH method for 
determining threshold could be reliably measured in the ECRL. The 
FCR Hmax showed fair reliability (ICC = 0.62), with a <5% decrease in 
amplitude between testing sessions. Unlike the ECRL HGN, however, 
there was no reliability in the FCR HGN (ICC = −0.04), though the 
between-day reliability for FCR HTH improved (ICC = 0.49). Overall, 
the FCR visHTH was the most-reliable measure for this muscle (ICC = 
0.76), with no effect between days 1 and 2. 
 
Fig. 2. H-reflex measures in the affected UE. (A) Panels show subject variation 
between the first two days of baseline testing. Individual subjects (grey lines), group 
means/SD (black lines), and ICC values are shown. (B) Schematic for the NMES study. 
(C) For subjects in the final analysis, NMES, but not walking increased ECRL Hmax. 
(D) NMES improves UE sensorimotor impairment (Fugl-Meyer) and UE 
speed/coordination (Box and Block). *p < 0.05.  
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Table 2. Baseline UE H-reflex parameters during chronic stroke. 
 
 n  
Day 1 
(mean/SD) 
Day 2 
(mean/SD) 
Effect of day on 
baseline measures 
ICC 
Typical 
error 
Typical 
percent 
error 
ECRL        
 
Hmax 
11 48 ± 21% 38 ± 15% 
F1, 10 = 2.33; p = 
0.04 
0.71 10.52% 21.91% 
 HGN 11 107 ± 84% 123 ± 117% 
F1, 10 = 0.57; p = 
0.58 
0.74 67.22% 62.72% 
 HTH 10 72 ± 18% 101 ± 66% F1, 9 = 1.38; p = 0.20 0.03 47.26% 65.53% 
 
visHTH 
16 74 ± 13% 79 ± 14% 
F1, 15 = 1.35; p = 
0.20 
0.36 11.07% 15.04% 
FCR        
 
Hmax 
15 44 ± 22% 40 ± 21% 
F1, 14 = 0.79; p = 
0.44 
0.62 15.96% 36.17% 
 HGN 15 134 ± 147% 114 ± 82% 
F1, 14 = 0.46; p = 
0.65 
−0.04 121.47% 90.75% 
 HTH 14 111 ± 97% 109 ± 52% 
F1, 13 = 0.11; p = 
0.91 
0.49 63.43% 56.93% 
 
visHTH 
17 79 ± 30% 80 ± 24% 
F1, 16 = 0.28; p = 
0.78 
0.76 13.39% 18.01% 
 
8.2. H-reflex and UE motor performance measurements 
following NMES 
In an effort to establish an unbiased method to include only 
participants with reliable measures, we removed 3 participants with a 
between-day change greater than 2 SD of the group mean from the 
larger SD of either day 1 or day 2 (subjects 3, 5, 14). Twelve 
additional participants did not pass our predetermined criteria for 
physiologically representative recruitment curves (e.g. lack of Mmax, 
high signal:noise ratio) at either the Post or Retention times for a 
specific muscle (Fig. 2B). Therefore, only half (i.e. 12 out of 24) 
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participants, with good reliability and physiologic recruitment curves at 
every time point, were included in the final cohort. 
Table 3 depicts group means for baseline (Pre), Post and 
Retention time points for all H-reflex parameters. Fig. 2C shows the 
group analysis for ECRL and FCR Hmax within the 95% confidence 
interval (n = 6 per group). While ECRL Hmax increased by 9% 
following walking in control participants, NMES increased the post 
Hmax by 19% (p = 0.08), and maintained this elevation by 12% at 
retention. Changes in ECRL Hmax were the only H-reflex changes to 
exceed typical error, which was 10.52% of Mmax for this measure. 
The FCR Control Post Hmax increased 5%, and additionally 12% at 
retention. Immediate post-NMES, FCR Hmax was unchanged from 
baseline, but Retention FCR Hmax decreased 5%. 
Table 3. H-reflex parameters in the affected UE following NMES. 
 
 Group n  Baseline 
(mean/SD) 
Post 
(mean/SD) 
Retention 
(mean/SD) 
Repeated measures 
ANOVA 
ECRL       
 Hmax Control 6 30 ± 13% 39 ± 17% 34 ± 17% F2, 5 = 1.55; p = 0.26 
 Intervention 6 36 ± 19% 55 ± 14% 48 ± 23% F2, 5 = 1.54; p = 0.26 
 HGN Control 6 50 ± 39% 134 ± 131% 60 ± 44% F2, 5 = 2.18; p = 0.16 
 Intervention 6 84 ± 56% 91 ± 84% 95 ± 62% F2, 5 = 0.04; p = 0.96 
 HTH Control 5 58 ± 25% 55 ± 41% 47 ± 27% F2, 4 = 0.43; p = 0.66 
 Intervention 5 81 ± 16% 54 ± 19% 67 ± 27% F2, 4 = 1.45; p = 0.29 
 visHTH Control 10 73 ± 16% 67 ± 17% 74 ± 18% F2, 9 = 1.49; p = 0.25 
 Intervention 13 71 ± 14% 63 ± 15% 64 ± 17% 
F2, 12 = 1.28; p = 
0.30 
FCR       
 Hmax Control 6 33 ± 21% 38 ± 21% 50 ± 34% F2, 5 = 3.00; p = 0.10 
 Intervention 6 42 ± 10% 41 ± 17% 37 ± 13% F2, 5 = 1.49; p = 0.27 
 HGN Control 5 108 ± 75% 133 ± 138% 193 ± 92% F2, 4 = 1.11; p = 0.38 
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 Group n  Baseline 
(mean/SD) 
Post 
(mean/SD) 
Retention 
(mean/SD) 
Repeated measures 
ANOVA 
 
Intervention 6 99 ± 61% 152 ± 213% 36 ± 37% F2, 5 = 1.40; p = 0.29 
 HTH Control 5 90 ± 15% 70 ± 21% 84 ± 16% F2, 4 = 1.77; p = 0.23 
 Intervention 5 79 ± 13% 74 ± 37% 79 ± 29% F2, 4 = 0.14; p = 0.87 
 visHTH Control 9 73 ± 17% 77 ± 17% 71 ± 16% F2, 8 = 0.93; p = 0.41 
 Intervention 14 76 ± 22% 74 ± 20% 85 ± 18% 
F2, 13 = 1.44; p = 
0.26 
 
A significant between-group effect in FM scores following NMES 
(F2, 14 = 7.47; p < 0.001) for the Intervention group showed 
improvement (baseline vs. Post; p < 0.01) that did not remain at 
retention (Table 4). There was also a trend for improvement in specific 
FM hand function following NMES (p = 0.051; Fig. 2), but not in UE 
wrist function or coordination and speed. While we have previously 
shown an effect of NMES on UE sensorimotor impairment when 
assessed using MASS [17] Post, we did not find a similar change after 
NMES in this study. NMES did, however, improve UE motor 
performance and coordination for the BB test. The blocks per minute in 
the Intervention group increased between baseline and Post (p < 
0.01) while the Control group showed no change. 
Table 4. NMES improves motor performance in the affected UE. 
 
 
Baseline 
(mean/SD) 
Post 
(mean/SD) 
Retention 
(mean/SD) 
Repeated measures ANOVA 
Control      
SIS hand 
function 
66 ± 38 71 ± 39 66 ± 37 F2, 9 = 2.18; p = 0.17 
physical 
domain 
70 ± 26 72 ± 25 75 ± 23 F2, 9 = 0.21; p = 0.82 
% Recovery 68 ± 20 66 ± 22 67 ± 22 F2, 9 = 0.06; p = 0.94 
Modified 
Ashworth 
3.5 ± 1.1 3.3 ± 3.6 3.4 ± 3.5 F2, 9 = 0.70; p = 0.52 
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Baseline 
(mean/SD) 
Post 
(mean/SD) 
Retention 
(mean/SD) 
Repeated measures ANOVA 
BB 
unaffected 
51 ± 15 51 ± 17 50 ± 16 F2, 9 = 0.06; p = 0.94 
Affected 34 ± 23 33 ± 23 34 ± 23 F2, 9 = 0.06; p = 0.95 
FM Hand 
function 
9.6 ± 5.0 9.6 ± 5.0 8.7 ± 4.9 F2, 9 = 0.22; p = 0.81 
Coordination 4.1 ± 2.2 3.5 ± 2.4 3.4 ± 2.3 F2, 9 = 0.86; p = 0.46 
Wrist 6.0 ± 3.4 5.6 ± 3.4 5.9 ± 3.2 F2, 9 = 0.45; p = 0.65 
Total 41.0 ± 19.9 40.7 ± 20.0 40.0 ± 20.1 F2, 9 = 0.02; p = 0.98 
Intervention      
SIS hand 
function 
37 ± 38 38 ± 38 38 ± 38 F2, 14 = 0.50; p = 0.62 
physical 
domain 
59 ± 24 57 ± 24 57 ± 24 F2, 14 = 0.04; p = 0.96 
% Recovery 55 ± 20 58 ± 18 59 ± 19 F2, 14 = 0.47; p = 0.64 
Modified 
Ashworth 
5.2 ± 3.9 4.7 ± 3.9 4.9 ± 3.9 F2, 14 = 0.89; p = 0.43 
BB 
unaffected 
50 ± 14 50 ± 16 52 ± 15 F2, 14 = 0.04; p = 0.96 
Affected 19 ± 24 20 ± 25 20 ± 26 F2, 14 = 9.8; p = 0.002* 
FM hand 
function 
6.1 ± 5.3 6.4 ± 5.6 6.7 ± 5.7 F2, 14 = 0.2.14; p = 0.16 
Coordination 3.2 ± 2.1 2.9 ± 2.1 2.7 ± 2.3 F2, 14 = 0.89; p = 0.43 
Wrist 3.8 ± 3.7 4.6 ± 3.7 4.1 ± 3.7 F2, 14 = 1.54; p = 0.25 
Total 31.9 ± 20.3 34.1 ± 20.4 32.6 ± 20.4 F2, 14 = 0.7.47; p = 0.006* 
SIS, Stoke impact scale; BB, box and block; FM, Fugl–Meyer. 
*p < 0.05. 
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9. Discussion 
The purpose of our study was two-fold: to establish a reliable 
protocol to measure UE H-reflexes after stroke, and to explore our 
hypothesis that H-reflex modulations contribute to the beneficial 
effects of NMES therapy. The H-reflex represents the monosynaptic 
connection between Ia muscle spindle fibers and the homonymous 
innervating motoneuron; the electrical equivalent of the spinal stretch 
reflex [3]. Lower extremity soleus H-reflex measurements have been 
useful in understanding spasticity and poor motor function after 
neurological injury [21,18]. UE H-reflex is only easily measured within 
ECRL and FCR, but not other forearm muscles [11], which has limited 
previous investigation [14,11]. We report that measuring ECRL and 
FCR H-reflexes in a single session was well tolerated in participants 
with prior stroke, despite the length of testing session, severity of 
deficit, or age of participant. 
Full recruitment curves characterize multiple facets of a 
muscle’s monosynaptic reflex excitability, including maximum 
recruited motoneurons (Hmax), stimulus thresholds for excitability 
(HTH), and the ease of additional motor unit recruitment (HGN) [20]. 
In contrast to healthy participants, chronic stroke-related hemiparesis 
reduced the number of statistically reliable H-reflex parameters. In 
particular, only ECRL Hmax and HGN, and to a lesser extent FCR Hmax 
and visHTH, were quantified in a consistent manner. The enhanced 
reliability of the ECRL over the FCR occurred previously [20] and may 
reflect anatomical influence on nerve stimulation and/or EMG 
recording. The mean ECRL and FCR Hmax for our participants were 
48% and 44%, respectively; twice the response in healthy participants 
[20]. This expected elevated UE Hmax [21] may be related to stroke 
induced spasticity of the affected limb [16]. 
The ECRL H-max magnitude declined significantly during 
baseline testing. It is well known that H-reflex amplitude is influenced 
by factors such as body orientation, limb position, activity in test 
muscles and muscles remote to test muscles, and anxiety. While we 
were successful in controlling the position of our subjects and we made 
an effort to control background activity in the test muscle, we did not 
monitor muscle activity or anxiety. Increased familiarity with the 
procedures on day 2 could have reduced subjects’ anxiety, resulting in 
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smaller values for ECRL Hmax. Moreover, the p-value of 0.04, with no 
adjustment for experiment-wise error, suggests that the day 1 to day 
2 drop in ECRL Hmax could be caused by type 1 error. If this effect is 
observed in subsequent studies, future protocols should monitor 
background muscle activity and ensure adequate familiarization with 
procedures to minimize uncontrolled influences on H-reflexes. 
Establishing between-day reliability for four participants was 
technically challenging in terms of obtaining a stable EMG signal and 
generation of true Mmax. While the latency was similar to healthy 
participants [20,14,9] and did not differ from results in stroke [12], 
consistently eliciting adequate EMG signals related to the reflex was 
difficult. This loss of response was evenly distributed between ECRL 
and FCR and did not correlate with functional deficit (data not shown). 
Offline analysis revealed several additional participants without true 
Mmax despite what appeared to be maximum peak-to-peak amplitude 
in the M wave during data collection. For future studies, designing a 
data collection program that generates real time recruitment curves 
during testing sessions will guarantee true Mmax. 
A 2008 meta-analysis of clinical trials for NMES intervention 
following stroke failed to show efficacy [13], though more recent 
publications show improved UE functional outcome in both acute [8] 
and chronic stroke survivors [19,17], including NMES delivered only to 
the ECRL [6]. A larger clinical trial using this protocol may determine if 
NMES promotes plasticity in the monosynaptic reflex in a use-
dependent manner, concomitant with enhanced motor recovery after 
stroke, particularly considering the trend for increased ECRL Hmax 
after NMES (p = 0.08). Moreover, NMES-induced changes in ECRL 
Hmax exceeded typical error, which suggests that these changes are 
clinically meaningful though a larger cohort of participants is needed to 
make sure that the effect is real and to adequately power the ANOVA. 
Power analysis of the ECRL Hmax change suggests that a minimum of 
18 participants would adequately assess modulation of this variable by 
NMES. 
Both H-reflex testing of agonist–antagonist UE muscles, and 
inhome NMES therapy, are well tolerated in participants with prior 
stroke and offer new possibilities for research into reflex-driven 
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plasticity during UE pathology and treatment of UE functional 
disability. 
Highlights 
 First protocol to measure agonist–antagonist H-reflexes in the 
hemiparetic arm. 
 In-home NMES therapy is well tolerated after stroke and 
improves UE function. 
 NMES strengthened the maximum H-reflex amplitude in the 
ECRL of the affected arm. 
 Agonist-antagonist UE H-reflex testing offers new possibilities 
for research into modulation of reflexes after stroke. 
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